Follow
Lisa VanWagner
Title
Cited by
Cited by
Year
Heart disease and stroke statistics—2020 update: a report from the American Heart Association
SS Virani, A Alonso, EJ Benjamin, MS Bittencourt, CW Callaway, ...
Circulation 141 (9), e139-e596, 2020
14858*2020
American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee
EJ Benjamin, P Muntner, A Alonso, MS Bittencourt, CW Callaway, ...
Heart disease and stroke statistics-2019 update: a report from the American …, 2019
29652019
American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee
SS Virani, A Alonso, EJ Benjamin, MS Bittencourt, CW Callaway, ...
Heart disease and stroke statistics-2020 update: a report from the American …, 2020
22262020
Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population‐based study
LB VanWagner, JE Wilcox, LA Colangelo, DM Lloyd‐Jones, JJ Carr, ...
Hepatology 62 (3), 773-783, 2015
2962015
Redefining cirrhotic cardiomyopathy for the modern era
M Izzy, LB VanWagner, G Lin, M Altieri, JY Findlay, JK Oh, KD Watt, ...
Hepatology 71 (1), 334-345, 2020
2512020
Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events
LB VanWagner, M Bhave, HS Te, J Feinglass, L Alvarez, ME Rinella
Hepatology 56 (5), 1741-1750, 2012
2422012
Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial
LB Van Wagner, SWP Koppe, EM Brunt, J Gottstein, K Gardikiotes, ...
Annals of hepatology 10 (3), 277-286, 2016
2112016
High early cardiovascular mortality after liver transplantation
LB VanWagner, B Lapin, J Levitsky, JT Wilkins, MM Abecassis, AI Skaro, ...
Liver transplantation 20 (11), 1306-1316, 2014
1952014
Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals
SB Prenner, LB VanWagner, SL Flamm, R Salem, RJ Lewandowski, ...
Journal of hepatology 66 (6), 1173-1181, 2017
1802017
Factors associated with major adverse cardiovascular events after liver transplantation among a national sample
LB VanWagner, M Serper, R Kang, J Levitsky, S Hohmann, M Abecassis, ...
American Journal of Transplantation 16 (9), 2684-2694, 2016
1712016
American heart association council on E, prevention statistics c, stroke statistics s. heart disease and stroke statistics-2019 update: a report from the American heart association
EJ Benjamin, P Muntner, A Alonso, MS Bittencourt, CW Callaway, ...
Circulation 139 (10), e56-e528, 2019
1632019
Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study
LB VanWagner, H Ning, CE Lewis, CM Shay, J Wilkins, JJ Carr, JG Terry, ...
Atherosclerosis 235 (2), 599-605, 2014
1492014
Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: an evaluation of the evidence and consensus recommendations
LB VanWagner, ME Harinstein, JR Runo, C Darling, M Serper, S Hall, ...
American Journal of Transplantation 18 (1), 30-42, 2018
1372018
North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension
JR Boike, BG Thornburg, SK Asrani, MB Fallon, BE Fortune, MJ Izzy, ...
Clinical Gastroenterology and Hepatology 20 (8), 1636-1662. e36, 2022
1232022
Extrahepatic manifestations of nonalcoholic fatty liver disease
LB VanWagner, ME Rinella
Current hepatology reports 15 (2), 75-85, 2016
1162016
The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis
LB Van Wagner, ME Rinella
Therapeutic advances in gastroenterology 4 (4), 249-263, 2011
1092011
Gestational diabetes mellitus is strongly associated with non-alcoholic fatty liver disease
VH Ajmera, EP Gunderson, LB VanWagner, CE Lewis, JJ Carr, ...
Official journal of the American College of Gastroenterology| ACG 111 (5 …, 2016
1032016
A point‐based prediction model for cardiovascular risk in orthotopic liver transplantation: the CAR‐OLT score
LB VanWagner, H Ning, M Whitsett, J Levitsky, S Uttal, JT Wilkins, ...
Hepatology 66 (6), 1968-1979, 2017
1012017
Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review
M Whitsett, LB VanWagner
World journal of hepatology 7 (16), 2041, 2015
1002015
Longitudinal association of non‐alcoholic fatty liver disease with changes in myocardial structure and function: the CARDIA study
LB VanWagner, JE Wilcox, H Ning, CE Lewis, JJ Carr, ME Rinella, ...
Journal of the American Heart Association 9 (4), e014279, 2020
972020
The system can't perform the operation now. Try again later.
Articles 1–20